A 38-year-old woman from Delhi undergoes colposcopy for abnormal Pap smear. Colposcopic examination reveals a 2 cm acetowhite lesion with coarse punctation and sharp margins in the transformation zone. Directed cervical biopsy confirms CIN 3 (cervical intraepithelial neoplasia grade 3). The lesion does not extend to the margins of the biopsy specimen. What is the most appropriate management?

Explanation

## Clinical Context Biopsy-confirmed CIN 3 is a high-grade lesion with significant risk of progression to invasive cancer if untreated (up to 30% over 30 years). Excisional treatment with margin assessment is the standard of care. ## Excisional vs. Ablative Treatment **Key Point:** CIN 3 requires **excisional** (not ablative) treatment because: 1. Histology must confirm complete removal and negative margins. 2. Ablative procedures (cryotherapy, laser ablation) destroy tissue without allowing margin assessment. 3. Risk of occult invasive disease in CIN 3 is ~1–2%; excision allows detection. ## LEEP vs. Cold Knife Conization | Feature | LEEP | Cold Knife Conization | |---------|------|----------------------| | Technique | Radiofrequency loop wire | Surgical blade | | Thermal artifact | Present (may obscure margins) | Minimal | | Specimen quality | Good for CIN 2/3 | Superior margin clarity | | Cost | Lower | Higher | | Availability | Widely available | Requires OR | | NEET PG preference | Acceptable for CIN 3 | Gold standard | **High-Yield:** Modern LEEP with careful technique and proper specimen orientation is now considered equivalent to cold knife conization for CIN 3 management in most guidelines (ASCCP 2019, FIGO). LEEP is more practical and cost-effective in resource-limited settings. **Clinical Pearl:** The key is **margin assessment**—whether LEEP or cold knife, the specimen must be submitted for histopathology to confirm: - Complete removal of CIN 3 - Negative ectocervical and endocervical margins - Absence of invasive disease ## Post-Treatment Surveillance After excisional treatment for CIN 3: 1. **Colposcopy + cytology at 6 months** (or HPV testing at 12 months). 2. **Annual surveillance for 25 years** (risk of recurrence ~5–15%). 3. **Hysterectomy is NOT indicated** after successful excision unless other gynecologic indications exist. **Warning:** Do NOT perform ablative procedures (cryotherapy, laser) for CIN 3 because margins cannot be assessed and occult invasive disease may be missed.